CoChat

Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers

Open access
Volpe, Massimo, Battistoni, Allegra, Tocci, Giuliano, Rosei, Enrico Agabiti, Catapano, Alberico L., Coppo, Rosanna, del Prato, Stefano, Gentile, Sandro, Mannarino, Elmo, Novo, Salvatore, Prisco, Domenico, Mancia, Giuseppe · 2012 · Journal of Hypertension
Cited by 108

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Cardiovascular risk assessment in the clinical practice is mostly based on risk charts, such as Framingham risk score and Systemic Coronary Risk Estimation (SCORE). These enable clinicians to estimate the impact of cardiovascular risk factors and assess individual cardiovascular risk profile. Risk charts, however, do not take into account subclinical organ damage, which exerts independent influence on risk and may amplify the estimated risk profile. Inclusion of organ damage markers in the assessment may thus contribute to improve this process. OBJECTIVE: Our aim was to evaluate the influence of implementation of SCORE charts with widely available indexes of organ damage, with the purpose to ameliorate individual risk assessment. METHODOLOGY: We searched www.Pubmed.gov for evidence about the predictive value of left ventricular hypertrophy (LVH), estimated glomerular filtration rate (eGFR), microalbuminuria (MAU) and metabolic syndrome on different risk profiles estimated by SCORE. Interventional and observational trials including at least 200 patients and published after 2000 were selected. RESULTS: The presence of organ damage as well as the number of abnormal parameters indicating organ damage is associated with increased cardiovascular risk, independently of SCORE. In the area of high risk, the impact of different markers of organ damage is heterogeneous. Combined risk models of SCORE and subclinical organ damage have major impact on risk stratification and may impact on recommendation in primary prevention in all SCORE categories. CONCLUSION: Available evidence suggests a tangible clinical advantage of adding the evaluation of simple organ damage markers to risk charts in cardiovascular risk prediction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/hjh.0b013e3283525715

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 108

Metadata

Authors
Volpe, M., Battistoni, A., Tocci, G., Rosei, E. A., Catapano, A. L., Coppo, R., del Prato, S., Gentile, S., Mannarino, E., Novo, S., Prisco, D., & Mancia, G.
Venue
Journal of Hypertension
Published
2012-06
Volume
30
Issue
6
Pages
1056-1064
ISSN
0263-6352 (ISSN-L)
OpenAlex
W2056421541
Cited by
108
References
14
FWCI
13.31
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers. https://app.cochat.ai/papers/10.1097/hjh.0b013e3283525715
The paper
Volpe, M., Battistoni, A., Tocci, G., Rosei, E. A., Catapano, A. L., Coppo, R., del Prato, S., Gentile, S., Mannarino, E., Novo, S., Prisco, D., & Mancia, G. (2012). Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e3283525715

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.